AbbVie Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +9.5%
EBITDA: +14.2%
EBIT: +72.2%
EPS: -13.3%
Free cash flow: +35.6%
Operating cash flow: +29.4%

Forward estimates

Revenue: +9.7%
EBITDA: +53.6%
EPS: +642.6%

Three-year CAGR

Revenue: +1.8%
EBITDA: -10.0%
EBIT: +3.5%
Net income: -29.1%
EPS: -29.1%
Free cash flow: -9.8%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.